Expression of lipocortins in human bronchial epithelial cells: effects of IL-1, TNF, LPS and dexamethasone
1996

Expression of Lipocortins in Human Bronchial Epithelial Cells

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): M. M. Verheggen, H. I. M. de Bont, P. W. C. Adriaansen-Soeting, B. J. A. Goense, C. J. A. M. Tak, H. C. Hoogsteden, P. Th. W. van Hal, M. A. Versnel

Primary Institution: Erasmus University and Academic Hospital Dijkzigt, Rotterdam, The Netherlands

Hypothesis

The study investigates whether lipocortin I and II can be induced by glucocorticoids in human bronchial epithelial cells.

Conclusion

The study found that lipocortin I and II are expressed in human bronchial epithelial cells, but their expression is not increased by glucocorticoids.

Supporting Evidence

  • Immunoperoxidase staining showed strong expression of lipocortin I and II in bronchial epithelium.
  • More than 99% of BEAS 2B cells were positive for intracellular lipocortin I and II.
  • Incubation with IL-1, TNF, or LPS significantly increased PGE2 and 6-keto-PGF production.

Takeaway

The cells in our lungs can make special proteins called lipocortins, but giving them medicine like dexamethasone doesn't make them produce more of these proteins.

Methodology

The study used immunoperoxidase staining, FACScan analysis, and Northern blotting to assess lipocortin expression in bronchial epithelial cells.

Limitations

The study had a small sample size and did not explore all potential factors affecting lipocortin expression.

Participant Demographics

Bronchial tissue was obtained from one female and two male non-asthmatic patients undergoing surgery for lung cancer.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication